Precise control of selectivity in hydrogenation reactions is a long-standing challenge. Surface decoration of nanocatalysts with transition-metal oxide nanoparticles (NPs) is an effective strategy to tailor the catalytic selectivity but generally at the expense of activity due to the blocking of active sites. Here, we report that constructing single-site metal oxide modifiers (NiO, CoO x , or FeO x ) on supported Au NPs by atomic layer deposition (ALD) can regulate their catalytic selectivity for nitroaromatic hydrogenation. The coverage of single-site metal oxide can be precisely tuned by altering the number of ALD cycles. The Au/TiO2 decorated with five cycles of NiO (Ni: 0.32 wt %) in the style of a single site can efficiently change the product selectivity from azo to azoxy compounds without significantly blocking the surface active sites. The density functional theory calculations indicate that the azoxybenzene bonded to the single-site NiO-decorated Au(111) with a larger adsorption energy, which inhibits the overhydrogenation of azoxybenzene and results in high azoxybenzene selectivity. Our work has demonstrated a general and efficient way to regulate the reaction selectivity of metal nanocatalysts by anchoring single-site metal oxide promoters.

SummaryDe novo ASXL1 mutations are found in patients with Bohring-Opitz syndrome, a disease with severe developmental defects and early childhood mortality. The underlying pathologic mechanisms remain largely unknown. Using Asxl1-targeted murine models, we found that Asxl1 global loss as well as conditional deletion in osteoblasts and their progenitors led to significant bone loss and a markedly decreased number of bone marrow stromal cells (BMSCs) compared with wild-type littermates. Asxl1−/− BMSCs displayed impaired self-renewal and skewed differentiation, away from osteoblasts and favoring adipocytes. RNA-sequencing analysis revealed altered expression of genes involved in cell proliferation, skeletal development, and morphogenesis. Furthermore, gene set enrichment analysis showed decreased expression of stem cell self-renewal gene signature, suggesting a role of Asxl1 in regulating the stemness of BMSCs. Importantly, re-introduction of Asxl1 normalized NANOG and OCT4 expression and restored the self-renewal capacity of Asxl1−/− BMSCs. Our study unveils a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development.